About Andrew Lee
Form D filings for EnPlusOne Biosciences from 2022 to 2024 list Andrew Lee as director.
Andrew Lee first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Andrew Lee in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Andrew Lee works with at each company, as listed on that company's latest Form D.
EnPlusOne Biosciences Inc. · Form D/A, Dec 26, 2024
DA
Daniel Ahlstedt
Chief OperatingOfficer and director
DW
Daniel Wiegand
Executive officer and director
SK
Steven Kasok
Director
DJ
Daniel Janse
Director